201 related articles for article (PubMed ID: 29928869)
1. Focal cryoballoon versus radiofrequency ablation of dysplastic Barrett's esophagus: impact on treatment response and postprocedural pain.
van Munster SN; Overwater A; Haidry R; Bisschops R; Bergman JJGHM; Weusten BLAM
Gastrointest Endosc; 2018 Nov; 88(5):795-803.e2. PubMed ID: 29928869
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study.
van Vilsteren FG; Alvarez Herrero L; Pouw RE; Schrijnders D; Sondermeijer CM; Bisschops R; Esteban JM; Meining A; Neuhaus H; Parra-Blanco A; Pech O; Ragunath K; Rembacken B; Schenk BE; Visser M; ten Kate FJ; Meijer SL; Reitsma JB; Weusten BL; Schoon EJ; Bergman JJ
Endoscopy; 2013 Jul; 45(7):516-25. PubMed ID: 23580412
[TBL] [Abstract][Full Text] [Related]
3. Liquid Nitrogen Spray Cryotherapy is Associated With Less Postprocedural Pain Than Radiofrequency Ablation in Barrett's Esophagus: A Multicenter Prospective Study.
Solomon SS; Kothari S; Smallfield GB; Inamdar S; Stein P; Rodriguez VA; Sima AP; Bittner K; Zfass AM; Kaul V; Trindade AJ
J Clin Gastroenterol; 2019 Feb; 53(2):e84-e90. PubMed ID: 29351156
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia.
Pouw RE; Wirths K; Eisendrath P; Sondermeijer CM; Ten Kate FJ; Fockens P; Devière J; Neuhaus H; Bergman JJ
Clin Gastroenterol Hepatol; 2010 Jan; 8(1):23-9. PubMed ID: 19602454
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of liquid nitrogen cryotherapy after failed radiofrequency ablation for Barrett's esophagus.
Trindade AJ; Inamdar S; Kothari S; Berkowitz J; McKinley M; Kaul V
Dig Endosc; 2017 Sep; 29(6):680-685. PubMed ID: 28303613
[TBL] [Abstract][Full Text] [Related]
6. Simplified versus standard regimen for focal radiofrequency ablation of dysplastic Barrett's oesophagus: a multicentre randomised controlled trial.
Pouw RE; Künzli HT; Bisschops R; Sondermeijer CM; Koch AD; Didden P; Gotink AW; Schoon EJ; Curvers WL; Bergman JJGHM; Weusten BLAM
Lancet Gastroenterol Hepatol; 2018 Aug; 3(8):566-574. PubMed ID: 29934224
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation and endoscopic resection in a single session for Barrett's esophagus containing early neoplasia: a feasibility study.
van Vilsteren FG; Alvarez Herrero L; Pouw RE; Visser M; Ten Kate FJ; van Berge Henegouwen MI; Schoon EJ; Weusten BL; Bergman JJ
Endoscopy; 2012 Dec; 44(12):1096-104. PubMed ID: 23108809
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Barrett's esophagus with a novel focal cryoablation device: a safety and feasibility study.
Schölvinck DW; Künzli HT; Kestens C; Siersema PD; Vleggaar FP; Canto MI; Cosby H; Abrams JA; Lightdale CJ; Tejeda-Ramirez E; DeMeester SR; Greene CL; Jobe BA; Peters J; Bergman JJ; Weusten BL
Endoscopy; 2015 Dec; 47(12):1106-12. PubMed ID: 26158241
[TBL] [Abstract][Full Text] [Related]
9. Spray cryotherapy versus continued radiofrequency ablation in persistent Barrett's esophagus.
Genere JR; Visrodia K; Zakko L; Hoefnagel SJM; Wang KK
Dis Esophagus; 2022 May; 35(5):. PubMed ID: 35059707
[TBL] [Abstract][Full Text] [Related]
10. The course of pain and dysphagia after radiofrequency ablation for Barrett's esophagus-related neoplasia.
Overwater A; Elias SG; Schoon EJ; Bergman JJGHM; Pouw RE; Weusten BLAM
Endoscopy; 2023 Mar; 55(3):255-260. PubMed ID: 36070753
[TBL] [Abstract][Full Text] [Related]
11. Salvage cryotherapy after failed radiofrequency ablation for Barrett's esophagus-related dysplasia is safe and effective.
Sengupta N; Ketwaroo GA; Bak DM; Kedar V; Chuttani R; Berzin TM; Sawhney MS; Pleskow DK
Gastrointest Endosc; 2015 Sep; 82(3):443-8. PubMed ID: 25887715
[TBL] [Abstract][Full Text] [Related]
12. Comparative outcomes of radiofrequency ablation and cryoballoon ablation in dysplastic Barrett's esophagus: a propensity score-matched cohort study.
Agarwal S; Alshelleh M; Scott J; Dhaliwal L; Codipilly DC; Dierkhising R; Leggett CL; Wang KK; Otaki FA; Trindade AJ; Iyer PG
Gastrointest Endosc; 2022 Mar; 95(3):422-431.e2. PubMed ID: 34624303
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation compared with argon plasma coagulation after endoscopic resection of high-grade dysplasia or stage T1 adenocarcinoma in Barrett's esophagus: a randomized pilot study (BRIDE).
Peerally MF; Bhandari P; Ragunath K; Barr H; Stokes C; Haidry R; Lovat L; Smart H; Harrison R; Smith K; Morris T; de Caestecker JS
Gastrointest Endosc; 2019 Apr; 89(4):680-689. PubMed ID: 30076843
[TBL] [Abstract][Full Text] [Related]
14. A simplified regimen for focal radiofrequency ablation of Barrett's mucosa: a randomized multicenter trial comparing two ablation regimens.
van Vilsteren FG; Phoa KN; Alvarez Herrero L; Pouw RE; Sondermeijer CM; Visser M; Ten Kate FJ; van Berge Henegouwen MI; Weusten BL; Schoon EJ; Bergman JJ
Gastrointest Endosc; 2013 Jul; 78(1):30-8. PubMed ID: 23528655
[TBL] [Abstract][Full Text] [Related]
15. Simplified protocol for focal radiofrequency ablation using the HALO90 device: short-term efficacy and safety in patients with dysplastic Barrett's esophagus.
Künzli HT; Schölvinck DW; Phoa KN; Schoon EJ; Houben MH; Bergman JJ; Weusten BL
Endoscopy; 2015 Jul; 47(7):592-7. PubMed ID: 25675174
[TBL] [Abstract][Full Text] [Related]
16. The safety and efficacy of radiofrequency ablation following endoscopic submucosal dissection for Barrett's neoplasia.
Subramaniam S; Kandiah K; Chedgy F; Meredith P; Longcroft-Wheaton G; Bhandari P
Dis Esophagus; 2018 Mar; 31(3):. PubMed ID: 29211875
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic radiofrequency ablation combined with endoscopic resection for early neoplasia in Barrett's esophagus longer than 10 cm.
Alvarez Herrero L; van Vilsteren FG; Pouw RE; ten Kate FJ; Visser M; Seldenrijk CA; van Berge Henegouwen MI; Fockens P; Weusten BL; Bergman JJ
Gastrointest Endosc; 2011 Apr; 73(4):682-90. PubMed ID: 21292262
[TBL] [Abstract][Full Text] [Related]
18. Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry.
Haidry RJ; Lipman G; Banks MR; Butt MA; Sehgal V; Graham D; Dunn JM; Gupta A; Sweis R; Miah H; Morris D; Smart HL; Bhandari P; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Veitch A; Dhar A; Nyalender D; Ragunath K; Leahy A; Fullard M; Rodriguez-Justo M; Novelli M; Lovat LB
Endoscopy; 2015 Nov; 47(11):980-7. PubMed ID: 26126159
[TBL] [Abstract][Full Text] [Related]
19. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial.
van Vilsteren FG; Pouw RE; Seewald S; Alvarez Herrero L; Sondermeijer CM; Visser M; Ten Kate FJ; Yu Kim Teng KC; Soehendra N; Rösch T; Weusten BL; Bergman JJ
Gut; 2011 Jun; 60(6):765-73. PubMed ID: 21209124
[TBL] [Abstract][Full Text] [Related]
20. Quality of life following radiofrequency ablation of dysplastic Barrett's esophagus.
Shaheen NJ; Peery AF; Hawes RH; Rothstein RI; Spechler SJ; Galanko JA; Campbell M; Carr C; Fowler B; Walsh J; Siddiqui AA; Infantolino A; Wolfsen HC;
Endoscopy; 2010 Oct; 42(10):790-9. PubMed ID: 20886398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
